Renal outcomes with dipeptidyl peptidase-4 inhibitors

Scheen, AJ; Delanaye, P

Scheen, AJ (reprint author), CHU Sart Tilman, Dept Med, Div Diabet Nutr & Metab Disorders, B35, B-4000 Liege 1, Belgium.; Scheen, AJ (reprint author), Univ Liege, Clin Pharmacol Unit, CHU Liege, CIRM, Liege, Belgium.

DIABETES & METABOLISM, 2018; 44 (2): 101

Abstract

Dipeptidyl peptidase-4 inhibitors (DPP-4is) are increasingly being used in the management of type 2 diabetes (T2D). The present review summarizes the ......

Full Text Link